Technical Analysis for SLRX - Salarius Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
F 1.19 -8.46% -0.11
SLRX closed down 8.46 percent on Thursday, April 15, 2021, on 34 percent of normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical SLRX trend table...

Date Alert Name Type % Chg
200 DMA Support Bullish 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Bullish Engulfing Bullish -8.46%
Lower Bollinger Band Walk Weakness -8.46%
Lower Bollinger Band Touch Weakness -8.46%
Oversold Stochastic Weakness -8.46%
Narrow Range Bar Range Contraction -6.30%
Older End-of-Day Signals for SLRX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
200 DMA Support about 18 hours ago
Down 1 ATR about 20 hours ago
Fell Below 200 DMA about 20 hours ago
Down 10% about 20 hours ago
60 Minute Opening Range Breakdown about 23 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Salarius Pharmaceuticals, Inc. a clinical-stage oncology company, develops therapies for the treatment of patients with various cancers. The company's lead candidate is Seclidemstat, which is in clinical development for the treatment of Ewing sarcoma, as well as advanced solid tumors, including prostate, breast, and ovarian cancers. Salarius Pharmaceuticals, Inc. is headquartered in Houston, Texas.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Clinical Development Solid Tumors Oncology Cancers Breast Cancer Prostate Cancer Treatment Of Breast Cancer Ovarian Cancer Sarcoma Advanced Solid Tumors Ovarian Cancers

Is SLRX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 3.5
52 Week Low 0.5602
Average Volume 2,887,897
200-Day Moving Average 1.17
50-Day Moving Average 1.72
20-Day Moving Average 1.41
10-Day Moving Average 1.37
Average True Range 0.14
ADX 9.06
+DI 18.71
-DI 28.21
Chandelier Exit (Long, 3 ATRs ) 1.21
Chandelier Exit (Short, 3 ATRs ) 1.55
Upper Bollinger Band 1.59
Lower Bollinger Band 1.23
Percent B (%b) -0.1
BandWidth 26.13
MACD Line -0.09
MACD Signal Line -0.08
MACD Histogram -0.0131
Fundamentals Value
Market Cap 23.61 Million
Num Shares 19.8 Million
EPS -176.44
Price-to-Earnings (P/E) Ratio -0.01
Price-to-Sales 1.63
Price-to-Book 0.66
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.46
Resistance 3 (R3) 1.46 1.38 1.41
Resistance 2 (R2) 1.38 1.31 1.38 1.40
Resistance 1 (R1) 1.29 1.27 1.25 1.28 1.38
Pivot Point 1.20 1.20 1.18 1.20 1.20
Support 1 (S1) 1.11 1.14 1.07 1.10 1.00
Support 2 (S2) 1.03 1.09 1.02 0.98
Support 3 (S3) 0.93 1.03 0.97
Support 4 (S4) 0.92